MicroRNA-16-5p controls development of osteoarthritis by targeting SMAD3 in chondrocytes

Current Pharmaceutical Design

Volumn 21, Issue 35, 2015, Pages 5160-5167

  Li, Lisong ^a,b   Jia, Jie ^a   Liu, Xianzhe ^a   Yang, Shuhua ^a   Ye, Shunan ^a   Yang, Wen ^a   Zhang, Yukun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Chondrocytes; miR 16 5p; Osteoarthritis; SMAD3

Indexed keywords

AGGRECAN; AGGRECANASE 1; AGGRECANASE 2; COLLAGEN TYPE 2; COLLAGENASE 3; MESSENGER RNA; MICRORNA; MICRORNA 16 5P; SMAD3 PROTEIN; STROMELYSIN; UNCLASSIFIED DRUG; MIRN16 MICRORNA, HUMAN; SMAD3 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BIOINFORMATICS; CARTILAGE; CARTILAGE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DISABLED PERSON; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; KNEE OSTEOARTHRITIS; LUCIFERASE ASSAY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VALIDATION STUDY; WESTERN BLOTTING; BIOLOGY; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CHONDROCYTES; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OSTEOARTHRITIS, KNEE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMAD3 PROTEIN; TRANSFECTION;

EID: 84947969760     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612821666150909094712     Document Type: Article

References (32)

1. Pun YL, Moskowitz RW, Lie S, et al. Clinical correlations of osteoarthritis associated with a single-base mutation (arginine-519 to cysteine) in type II procollagen gene: A newly defined pathogenesis. Arthritis Rheum 1994; 37: 264-9.
2. Leong DJ, Sun HB. Events in articular chondrocytes with aging. Curr Osteoporosis Reports 2011; 9: 196-201.
3. Goldring MB, Marcu KB. Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Therapy 2009; 11: 224.
4. Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 2013; 21: 16-21.
5. Alcaraz MJ, Megias J, Garcia-Arnandis I, et al. New molecular targets for the treatment of osteoarthritis. Biochem Pharmacol 2010; 80: 13-21.
6. Barter MJ, Bui C, Young DA. Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs. Osteoarthritis Cartilage 2012; 20: 339-49.
7. da Silva MA, Yamada N, Clarke NM, et al. Cellular and epigenetic features of a young healthy and a young osteoarthritic cartilage compared with aged control and OA cartilage. J Orthop Res 2009; 27: 593-601.
8. Imagawa K, de Andres MC, Hashimoto K, et al. The epigenetic effect of glucosamine and a nuclear factor-kappa B (NF-kB) inhibitor on primary human chondrocytes--implications for osteoarthritis. Biochem Biophys Res Commun 2011; 405: 362-7.
9. Reynard LN, Loughlin J. Genetics and epigenetics of osteoarthritis. Maturitas 2012; 71: 200-4.
10. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215-33.
11. Carthew RW, Sontheimer EJ. Origins and Mechanisms of miRNAs and siRNAs. Cell 2009; 136: 642-55.
12. Esau C, Davis S, Murray SF, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006; 3: 87-98.
13. He L, He X, Lowe SW, et al. microRNAs join the p53 network-- another piece in the tumour-suppression puzzle. Nat Rev Cancer 2007; 7: 819-22.
14. Chen CZ, Li L, Lodish HF, et al. MicroRNAs modulate hematopoietic lineage differentiation. Science 2004; 303: 83-86.
15. Ma L, Teruya-Feldstein J, Weinberg RA. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 2007; 449: 682-8.
16. Jones SW, Watkins G, Le Good N, et al. The identification of differentially expressed microRNA in osteoarthritic tissue that modulate the production of TNF-alpha and MMP13. Osteoarthritis Cartilage 2009; 17: 464-72.
17. Iliopoulos D, Malizos KN, Oikonomou P, et al. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 2008; 3: e3740.
18. Chen L, Wang Q, Wang GD, et al. miR-16 inhibits cell proliferation by targeting IGF1R and the Raf1-MEK1/2-ERK1/2 pathway in osteosarcoma. Febs Lett 2013; 587: 1366-72.
19. Ke Y, Zhao WY, Xiong J, et al. Downregulation of miR-16 promotes growth and motility by targeting HDGF in non-small cell lung cancer cells. Febs Lett 2013; 587: 3153-7.
20. Hanlon K, Rudin CE, Harries LW. Investigating the Targets of MIR-15a and MIR-16-1 in Patients with Chronic Lymphocytic Leukemia (CLL). Plos One 2009; 4: e7169.
21. Rivas MA, Venturutti L, Huang Y-W, et al. Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development. Breast Cancer Res 2012; 14: R77.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-8.
23. Yang B, Guo H, Zhang Y, et al. The microRNA expression profiles of mouse mesenchymal stem cell during chondrogenic differentiation. BMB Rep 2011; 44: 28-33.
24. Krek A, Grun D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet 2005; 37: 495-500.
25. Wang Q, Rozelle AL, Lepus CM, et al. Identification of a central role for complement in osteoarthritis. Nat Med 2011; 17: 1674-9.
26. Javelaud D, Mauviel A. Mammalian transforming growth factorbetas: Smad signaling and physio-pathological roles. Int J Biochem Cell Biol 2004; 36: 1161-5.
27. Roelen BA, Dijke P. Controlling mesenchymal stem cell differentiation by TGFBeta family members. J Orthop Sci 2003; 8: 740-8.
28. Valdes AM, Spector TD, Tamm A, et al. Genetic variation in the SMAD3 gene is associated with hip and knee osteoarthritis. Arthritis Rheum 2010; 62: 2347-52.
29. Roman-Blas JA, Stokes DG, Jimenez SA. Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthritis Cartilage 2007; 15: 1367-77.
30. Furumatsu T, Tsuda M, Taniguchi N, et al. Smad3 induces chondrogenesis through the activation of SOX9 via CREB-binding protein/ p300 recruitment. J Biol Chem 2005; 280: 8343-50.
31. Blaney Davidson EN, Remst DF, Vitters EL, et al. Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol 2009; 182: 7937-45.
32. Wu Q, Kim KO, Sampson ER, et al. Induction of an osteoarthritislike phenotype and degradation of phosphorylated Smad3 by Smurf2 in transgenic mice. Arthritis Rheum 2008; 58: 3132-44.